Nachrichten zur Corcept Therapeutics Inc. Aktie

Corcept Therapeutics (CORT) Q1 2022 Earnings Call Transcript

CORT earnings call for the period ending March 31, 2022....…

Corcept Therapeutics (CORT) Misses Q1 Earnings and Revenue Estimates

Corcept (CORT) delivered earnings and revenue surprises of -13.04% and 5.49%, respectively, for the quarter ended March 2022. Do the…

Form 8-K CORCEPT THERAPEUTICS For: May 05

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Corcept Therapeutics Announces Appointment of Three Senior Leaders

Key Hires Bring Diverse Expertise to Commercial and Development Initiatives Key Hires Bring Diverse Expertise to Commercial and Development Initiatives...…

Corcept Therapeutics Completes Enrollment in Phase 2 GRATITUDE Study of Miricorilant in Patients with Antipsychotic-Induced Weight Gain

Data to be Available in Fourth Quarter 2022 Data to be Available in Fourth Quarter 2022...…

Relacorilant Plus Nab-Paclitaxel Extends Survival in Women with Recurrent, Platinum-resistant Ovarian Cancer

MENLO PARK, Calif., March 30, 2022 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial stage company…

Insiderhandel: Chief Business Officer verkauft Aktien von Corcept Therapeutics im Wert von 123.054$

Robb, Gary Charles - Vorstand - Tag der Transaktion: 2022-03-18...…

Insiderhandel: Chief Business Officer verkauft Aktien von Corcept Therapeutics im Wert von 185.374$

Robb, Gary Charles - Vorstand - Tag der Transaktion: 2022-03-17...…

Corcept Therapeutics (CORT) Investor Presentation - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Corcept Therapeutics (CORT) Q4 2021 Earnings Call Transcript

CORT earnings call for the period ending December 31, 2021....…

Corcept Therapeutics Incorporated (CORT) CEO Joseph Belanoff On Q4 2021 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Corcept Therapeutics (CORT) Q4 Earnings Beat Estimates

Corcept (CORT) delivered earnings and revenue surprises of 18.18% and 2.32%, respectively, for the quarter ended December 2021. Do the…

Recap: Corcept Therapeutics Q4 Earnings

Corcept Therapeutics (NASDAQ:CORT) reported its Q4 earnings results on Tuesday, February 15, 2022 at 04:00 PM. Heres what investors need to…

Form 10-K CORCEPT THERAPEUTICS For: Dec 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT

NEW YORK, Jan. 27, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Inc.…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT

NEW YORK, Jan. 17, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Inc.…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT

NEW YORK, Jan. 6, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Inc.…

Corcept Therapeutics Announces Final Results of Previously Announced Tender Offer

MENLO PARK, Calif., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) (“Corcept”), a commercial-stage company…

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Inc. - CORT

NEW YORK, Dec. 13, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Inc.…

Why Corcept Therapeutics Stock Was Up 11.6% Friday

Investors may be looking for a bargain after the company was hit with bad news this week....…

Why Corcept Therapeutics Tanked by Almost 17% Today

A U.S. attorney is interested in the company for the wrong reasons....…

Corcept Therapeutics Shares Drop 21% After Tender Expiration Extended

Corcept Therapeutics Shares Drop 21% After Tender Expiration Extended...…

Corcept Therapeutics Incorporated (CORT) CEO Dr. Joseph Belanoff on Q3 2021 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Corcept Therapeutics Incorporated (CORT) Q3 2021 Earnings Call Transcript

CORT earnings call for the period ending September 30, 2021....…

Corcept Therapeutics (CORT) Q3 Earnings Top Estimates

Corcept (CORT) delivered earnings and revenue surprises of 26.32% and -1.65%, respectively, for the quarter ended September 2021. Do the…

Corcept Therapeutics Announces Third Quarter Financial Results And Provides Corporate Update

MENLO PARK, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged…

Corcept Therapeutics And Its Real Value

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call

MENLO PARK, Calif., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will…

Insiderhandel: Chief Commercial Officer verkauft Aktien von Corcept Therapeutics im Wert von 12.740$

Maduck, Sean - Vorstand - Tag der Transaktion: 2021-10-05...…

Insiderhandel: Chief Commercial Officer verkauft Aktien von Corcept Therapeutics im Wert von 487.375$

Maduck, Sean - Vorstand - Tag der Transaktion: 2021-10-01...…

Insiderhandel: Chief Business Officer verkauft Aktien von Corcept Therapeutics im Wert von 132.445$

Robb, Gary Charles - Vorstand - Tag der Transaktion: 2021-09-13...…

Insiderhandel: Chief Business Officer verkauft Aktien von Corcept Therapeutics im Wert von 16.736$

Robb, Gary Charles - Vorstand - Tag der Transaktion: 2021-09-14...…

Insiderhandel: Chief Business Officer verkauft Aktien von Corcept Therapeutics im Wert von 980.742$

Robb, Gary Charles - Vorstand - Tag der Transaktion: 2021-09-15...…

Corcept Announces Presentation of Positive Results From Randomized, Controlled, Phase 2 Trial of Relacorilant in Patients With Recurrent Platinum-Resistant Ovarian Cancer at ESMO 2021

MENLO PARK, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged…

William Guyer to join Corcept as Chief Development Officer

MENLO PARK, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged…

Insiderhandel: Chief Commercial Officer verkauft Aktien von Corcept Therapeutics im Wert von 529.420$

Maduck, Sean - Vorstand - Tag der Transaktion: 2021-08-03...…

Checking In On Corcept Therapeutics

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Corcept Therapeutics Incorporated (CORT) Q2 2021 Earnings Call Transcript

CORT earnings call for the period ending June 30, 2021....…

Corcept Therapeutics Incorporated (CORT) CEO Joseph Belanoff on Q2 2021 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Corcept Therapeutics (CORT) Q2 Earnings and Revenues Surpass Estimates

Corcept (CORT) delivered earnings and revenue surprises of 50.00% and 6.72%, respectively, for the quarter ended June 2021. Do the…

Former Gilead Sciences Executive Amy E. Flood Joins Corcept Therapeutics as Chief Human Resources and Communications Officer

MENLO PARK, Calif., July 12, 2021 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged…

Insiderhandel: Chief Commercial Officer verkauft Aktien von Corcept Therapeutics im Wert von 554.693$

Maduck, Sean - Vorstand - Tag der Transaktion: 2021-07-07...…